Caveolin-1 Alleviates Acetaminophen-Induced Fat Accumulation in Non-Alcoholic Fatty Liver Disease by Enhancing Hepatic Antioxidant Ability via Activating AMPK Pathway

• Κύριοι συγγραφείς: Jiarong Wang (Συγγραφέας), Wei Jiang (Συγγραφέας), Jiao Xin (Συγγραφέας), Weiju Xue (Συγγραφέας), Congjian Shi (Συγγραφέας), Jiagen Wen (Συγγραφέας), Yan Huang (Συγγραφέας), Chengmu Hu (Συγγραφέας)
• Μορφή: Βιβλίο
• Έκδοση: Frontiers Media S.A., 2021-07-01T00:00:00Z.
• Θέματα: article
• Διαθέσιμο Online: Connect to this object online.

Non-alcoholic fatty liver disease (NAFLD) is an independent risk factor for acute liver injury caused by overuse of acetaminophen (APAP). Caveolin-1 (CAV1), a regulator of hepatic energy metabolism and oxidative stress, was found to have a protective effect against NAFLD in our previous study. Howev...